Effect of Intravenous Acetaminophen on Mean Arterial Blood Pressure: A Post Hoc Analysis of the EFfect of Intravenous ACetaminophen on PosToperative HypOxemia After Abdominal SurgeRy Trial.


Journal

Anesthesia and analgesia
ISSN: 1526-7598
Titre abrégé: Anesth Analg
Pays: United States
ID NLM: 1310650

Informations de publication

Date de publication:
01 12 2021
Historique:
pubmed: 16 4 2021
medline: 15 12 2021
entrez: 15 4 2021
Statut: ppublish

Résumé

Acetaminophen is commonly used as part of multimodal analgesia for acute pain. The intravenous formulation offers a more predictable bioavailability compared to oral and rectal acetaminophen. There have been reports of hypotension with intravenous acetaminophen attributable to centrally mediated and vasodilatory effects. We tested the hypothesis that in adults having abdominal surgery the use of intravenous acetaminophen versus placebo for postoperative pain management is associated with a decrease in mean arterial pressure (MAP) after its administration. This is a substudy of eFfect of intravenous ACetaminophen on posToperative hypOxemia after abdominal surgeRy (FACTOR) trial (NCT02156154). FACTOR trial randomly assigned adults undergoing abdominal surgery to either 1 g of acetaminophen or placebo every 6 hours during the first postoperative 48 hours. Continuous monitoring of blood pressure was obtained by noninvasive ViSi Mobile device (Sotera Wireless, Inc, San Diego, CA) at 15-second intervals during initial 48 hours postoperatively. We excluded patients without continuous monitoring data available. The primary outcome was the MAP difference between MAP 5 minutes before study drug administration (baseline) and MAP 30 minutes poststudy drug administration initiation. We used a linear mixed effects model to assess the treatment effect on MAP change. The secondary outcome was MAP area under baseline (AUB) during the 30 minutes after treatment. In a sensitivity analysis of change in MAP from predrug to postdrug administration, we instead used postdrug MAP as the outcome adjusting for the baseline MAP in the model. Among 358 patients analyzed, 182 received acetaminophen and 176 placebo. The mean (standard deviation [SD]) of average MAP change was -0.75 (5.9) mm Hg for the treatment and 0.32 (6.3) mm Hg for the placebo. Acetaminophen was found to decrease the MAP from baseline more than placebo after drug administration. The estimated difference in mean change of MAP was -1.03 (95% confidence interval [CI] -1.60 to -0.47) mm Hg; P < .001. The sensitivity analysis showed postoperative MAP in the acetaminophen group was 1.33 (95% CI, 0.76-1.90) mm Hg lower than in the placebo group (P < .001). The median of MAP AUB was 33 [Q1 = 3.3, Q3 = 109] mm Hg × minutes for the treatment and 23 [1.6, 79] mm Hg × minutes for the placebo. Acetaminophen was found to increase the AUB with an estimated median difference of 15 (95% CI, 5-25) mm Hg × minutes (P = .003). Intravenous acetaminophen decreases MAP after its administration. However, this decrease does not appear to be clinically meaningful. Clinicians should not refrain to use intravenous acetaminophen for acute pain management because of worries of hypotension.

Sections du résumé

BACKGROUND
Acetaminophen is commonly used as part of multimodal analgesia for acute pain. The intravenous formulation offers a more predictable bioavailability compared to oral and rectal acetaminophen. There have been reports of hypotension with intravenous acetaminophen attributable to centrally mediated and vasodilatory effects. We tested the hypothesis that in adults having abdominal surgery the use of intravenous acetaminophen versus placebo for postoperative pain management is associated with a decrease in mean arterial pressure (MAP) after its administration.
METHODS
This is a substudy of eFfect of intravenous ACetaminophen on posToperative hypOxemia after abdominal surgeRy (FACTOR) trial (NCT02156154). FACTOR trial randomly assigned adults undergoing abdominal surgery to either 1 g of acetaminophen or placebo every 6 hours during the first postoperative 48 hours. Continuous monitoring of blood pressure was obtained by noninvasive ViSi Mobile device (Sotera Wireless, Inc, San Diego, CA) at 15-second intervals during initial 48 hours postoperatively. We excluded patients without continuous monitoring data available. The primary outcome was the MAP difference between MAP 5 minutes before study drug administration (baseline) and MAP 30 minutes poststudy drug administration initiation. We used a linear mixed effects model to assess the treatment effect on MAP change. The secondary outcome was MAP area under baseline (AUB) during the 30 minutes after treatment. In a sensitivity analysis of change in MAP from predrug to postdrug administration, we instead used postdrug MAP as the outcome adjusting for the baseline MAP in the model.
RESULTS
Among 358 patients analyzed, 182 received acetaminophen and 176 placebo. The mean (standard deviation [SD]) of average MAP change was -0.75 (5.9) mm Hg for the treatment and 0.32 (6.3) mm Hg for the placebo. Acetaminophen was found to decrease the MAP from baseline more than placebo after drug administration. The estimated difference in mean change of MAP was -1.03 (95% confidence interval [CI] -1.60 to -0.47) mm Hg; P < .001. The sensitivity analysis showed postoperative MAP in the acetaminophen group was 1.33 (95% CI, 0.76-1.90) mm Hg lower than in the placebo group (P < .001). The median of MAP AUB was 33 [Q1 = 3.3, Q3 = 109] mm Hg × minutes for the treatment and 23 [1.6, 79] mm Hg × minutes for the placebo. Acetaminophen was found to increase the AUB with an estimated median difference of 15 (95% CI, 5-25) mm Hg × minutes (P = .003).
CONCLUSIONS
Intravenous acetaminophen decreases MAP after its administration. However, this decrease does not appear to be clinically meaningful. Clinicians should not refrain to use intravenous acetaminophen for acute pain management because of worries of hypotension.

Identifiants

pubmed: 33856395
doi: 10.1213/ANE.0000000000005429
pii: 00000539-202112000-00021
doi:

Substances chimiques

Analgesics, Non-Narcotic 0
Acetaminophen 362O9ITL9D

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1532-1539

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 International Anesthesia Research Society.

Déclaration de conflit d'intérêts

Conflicts of Interest: See Disclosures at the end of the article.

Références

Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006;12:250–275.
Lee WM. Acetaminophen toxicity: changing perceptions on a social/medical issue. Hepatology. 2007;46:966–970.
Smith HS. Perioperative intravenous acetaminophen and NSAIDs. Pain Med. 2011;12:961–981.
Achuff BJ, Moffett BS, Acosta S, Lasa JJ, Checchia PA, Rusin CG. Hypotensive response to iv acetaminophen in pediatric cardiac patients. Pediatr Crit Care Med. 2020;19:527–533.
Maxwell EN, Johnson B, Cammilleri J, Ferreira JA. Intravenous acetaminophen-induced hypotension: a review of the current literature. Ann Pharmacother. 2019;53:1033–1041.
Yaman A, Demir B, Belen FB, et al. Paracetamol infusion-related severe hypotension and cardiac arrest in a child. Turk J Pediatr. 2016;58:550–553.
Boyle M, Nicholson L, O’Brien M, et al. Paracetamol induced skin blood flow and blood pressure changes in febrile intensive care patients: an observational study. Aust Crit Care. 2010;23:208–214.
Krajčová A, Matoušek V, Duška F. Mechanism of paracetamol-induced hypotension in critically ill patients: a prospective observational cross-over study. Aust Crit Care. 2013;26:136–141.
Mrozek S, Constantin JM, Futier E, et al. Acetaminophene-induced hypotension in intensive care unit: a prospective study. Ann Fr Anesth Reanim. 2009;28:448–453.
Ziemann-Gimmel P. Hypotension with acetaminophen–maybe there is a different mechanism. Aust Crit Care. 2011;24:150.
Cantais A, Schnell D, Vincent F, et al. Acetaminophen-induced changes in systemic blood pressure in critically ill patients: results of a multicenter cohort study. Crit Care Med. 2016;44:2192–2198.
Boyle M, Hundy S, Torda TA. Paracetamol administration is associated with hypotension in the critically ill. Aust Crit Care. 1997;10:120–122.
Chiam E, Weinberg L, Bellomo R. Paracetamol: a review with specific focus on the haemodynamic effects of intravenous administration. Heart Lung Vessel. 2015;7:121–132.
Beattie WS, Wijeysundera DN, Chan MTV, et al.; ANZCA Clinical Trials Network for the ENIGMA-II Investigators. Implication of major adverse postoperative events and myocardial injury on disability and survival: a planned subanalysis of the ENIGMA-II trial. Anesth Analg. 2018;127:1118–1126.
Sessler DI, Meyhoff CS, Zimmerman NM, et al. Period-dependent associations between hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death: a substudy of the POISE-2 trial. Anesthesiology. 2018;128:317–327.
Turan A, Essber H, Saasouh W, et al.; FACTOR Study Group. Effect of intravenous acetaminophen on postoperative hypoxemia after abdominal surgery: the FACTOR randomized clinical trial. JAMA. 2020;324:350–358.
Chiam E, Weinberg L, Bailey M, McNicol L, Bellomo R. The haemodynamic effects of intravenous paracetamol (acetaminophen) in healthy volunteers: a double-blind, randomized, triple crossover trial. Br J Clin Pharmacol. 2016;81:605–612.
Kelly SJ, Moran JL, Williams PJ, et al. Haemodynamic effects of parenteral vs. enteral paracetamol in critically ill patients: a randomised controlled trial. Anaesthesia. 2016;71:1153–1162.
Schell-Chaple HM, Liu KD, Matthay MA, Sessler DI, Puntillo KA. Effects of IV acetaminophen on core body temperature and hemodynamic responses in febrile critically ill adults: a randomized controlled trial. Crit Care Med. 2017;45:1199–1207.
Hersch M, Raveh D, Izbicki G. Effect of intravenous propacetamol on blood pressure in febrile critically ill patients. Pharmacotherapy. 2008;28:1205–1210.
Turan A, Chang C, Cohen B, et al. Incidence, severity, and detection of blood pressure perturbations after abdominal surgery: a prospective blinded observational study. Anesthesiology. 2019;130:550–559.
Moller PL, Sindet-Pedersen S, Petersen CT, Juhl GI, Dillenschneider A, Skoglund LA. Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery. Br J Anaesth. 2005;94:642–648.
Holmér Pettersson P, Owall A, Jakobsson J. Early bioavailability of paracetamol after oral or intravenous administration. Acta Anaesthesiol Scand. 2004;48:867–870.
Lee HY, Ban GY, Jeong CG, et al. Propacetamol poses a potential harm of adverse hypotension in male and older patients. Pharmacoepidemiol Drug Saf. 2017;26:256–264.

Auteurs

Mauro Bravo (M)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Omer Bakal (O)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Eva Rivas (E)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.
Department of Anesthesia, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universidad de Barcelona, Barcelona, Spain.

Edward J Mascha (EJ)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.
Department of Quantitative Health Sciences.

Xuan Pu (X)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.
Department of Quantitative Health Sciences.

Lauretta Mosteller (L)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Fabio Rodriguez-Patarroyo (F)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Hani Essber (H)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Ahmed AlGharrash (A)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.

Alparslan Turan (A)

From the Department of Outcomes Research, Cleveland Clinic, Cleveland, Ohio.
Department of General Anesthesiology, Cleveland Clinic, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH